Emera Inc. closed 1.2% short of its 52-week high of C$59.88, which the company achieved on March 11th.

Insulet shows bullish trends with strong growth, favorable Wall Street ratings, and a 3.2:1 reward-risk ratio. Read more on ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are now reviewing the supplemental New Drug Application (sNDA) for nusinersen, which includes a more rapid ...

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX: EMA) announced that at its Annual Meeting of Shareholders held on May ...

What has been 52-week high of EMA India Ltd stocks? The highest price of EMA India Ltd stock is ₹145.40 in the last 52-week. What is the share price of EMA India Ltd () today on BSE? As on Mar ...

Shares of EMA opened at C$57.28 on Monday. The firm’s 50 day moving average is C$54.56 and its 200-day moving average is C$52.85. The stock has ... a concise daily summary of the latest news ...

Emera (TSE:EMA – Get Free Report ... to an “outperform” rating and lifted their price objective for the stock from C$54.00 to C$58.00 in a research report on Monday, December 2nd.

Current market price: ₹ 1,752.35 | Buy range: ₹ 1,700–1,760 | Profit goal: ₹ 1,890 | Stop loss: ₹ 1,670 | Timeframe: 1–2 ...

Emera Inc. closed 2.0% below its 52-week high of C$59.88, which the company reached on March 11th.

The EMA India is operating in the Engineering - General Sector. It is classified as a Smallcap stock on the BSE. What is the Market Cap of EMA India? The market cap of EMA India is ₹13.37 Cr as ...